FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
Executive Summary
FDA and states should tighten drug wholesaler licensing requirements in a way that does not "unduly restrict the interstate business of wholesaling" by licensed companies, the Pharmaceutical Distributors Association says
You may also be interested in...
NACDS Anti-Counterfeit Proposal Would Use “One Forward/One Back” Model
FDA should require distributors to adopt a "one forward/one back" record keeping system for drug sales to prevent counterfeiting, the National Association of Chain Drug Stores recommended
NACDS Anti-Counterfeit Proposal Would Use “One Forward/One Back” Model
FDA should require distributors to adopt a "one forward/one back" record keeping system for drug sales to prevent counterfeiting, the National Association of Chain Drug Stores recommended
FDA-Approved Drug Wholesaler Inspection Program Recommended By HDMA
An FDA-approved national inspection program for drug wholesalers would ensure facilities are adequately inspected before being granted a license, the Healthcare Distribution Management Association said in Nov. 25 comments to the agency